在COVID-19患者中,炎症评分工具与螺旋计指数的关联:单一中心队列研究
Mohsen Farrokhpour1, Fahimeh Safarnezhad Tameshkel2, Niloufar Sadat Kalaki3,4
1Department of Internal Medicine, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Iranian journal of microbiology
|January 9, 2026
概括
像C反应蛋白 (CRP) 和中性粒细胞与淋巴细胞比率 (NLR) 这样的炎症标志物与COVID-19幸存者的肺功能 (呼吸量) 降低有关. 这些得分可以帮助预测出院后三个月的呼吸系统结果.
科学领域:
- 肺部医学 肺部医学
- 传染性疾病 传染性疾病
- 临床生物化学 临床生物化学
背景情况:
- COVID-19可能导致持续的呼吸道并发症,影响肺功能.
- 包括炎症评分在内的各种生物标志物与这些COVID-19后的肺部变化有关.
研究的目的:
- 调查COVID-19患者的炎症评分工具和螺旋计指数之间的关联.
- 评估炎症标志物在出院后三个月对呼吸道结果的预后价值.
主要方法:
- 分析了369名COVID-19患者的螺旋计数据,这些患者在基线和出院后三个月出现并发症.
- 使用通用线性模型和逻辑回归来进行统计比较.
主要成果:
- 三个月后,高C反应蛋白 (CRP),中性粒细胞与淋巴细胞比率 (NLR) 和APACHE II评分与关键螺旋计指数 (FEV1,FEV1/FVC) 呈反向关系.
- 与对照组相比,喘患者的FEV1和FEV1/FVC显著降低,喘患者和COPD患者之间的FVC没有显著差异.
结论:
- CRP,NLR和APACHE II分数是COVID-19幸存者的呼吸功能显著预测因素.
- 这些炎症标志物作为评估COVID-19后呼吸道疾病的预后有价值的指标.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
COPD: Management Using Bronchodilators and Corticosteroids
719
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
719
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Pulmonary Function Tests
726
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
726
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K


